Titan Biotech has announced a certificate confirming that all securities received for dematerialization during the quarter have been processed—accepted or rejected—and listed on relevant stock exchanges.

The physical share certificates have been verified, mutilated, and canceled, with ownership updated in the registrar’s records within 15 days.

This ensures smooth and compliant transfer of shares into electronic form, supporting efficient trading and safeguarding shareholder interests.